A comprehensive on-site review of your current processes is necessary to identify areas of risk.
Federal and state laws address the need for controlled substance monitoring and reporting
Much time and energy may be devoted to monitoring for drug diversion, and once suspected,
Federal and state laws address the need for controlled substance monitoring and reporting
As Rxpert Solutions’ lead consultant, Terri Vidals has years of experience in drug diversion monitoring
In the world of healthcare, the issue of drug diversion remains a critical concern. A recent case involving a Virginia pharmacist provides valuable insights into
The Need for Proactive Drug Diversion Mitigation Drug diversion in healthcare—where controlled substances are misappropriated for non-medical use—poses significant risks, not only to patient safety
Health Care Diversion
https://healthcarediversion.org
DEA Office of Diversion Control
https://www.deadiversion.usdoj.gov/
International Health Facility Diversion Association
https://ihfda.org/
Opioid prescribing
https://www.teaterhs.com/
Join me as I talk with Marsha and John from IHFDA on various topics. We touch on substance abuse disease, opioid prescribing, IHFDA, and illicit fentanyl. There is something in there for everyone!
Terri has been a pharmacist for over 30 years and is a drug diversion mitigation and monitoring subject matter expert. Her years of experience in various roles within hospital pharmacy have given her real-world insight into risk, compliance, and regulatory requirements, as well as best practices for medication and patient safety.
Subscribe to Drug Diversion Insights with Terri Vidals to learn more about diversion mitigation.
© Copyright 2023. All Rights Reserved.